Search Results

There are 7336691 results for: content related to: A stand against drug company advertising

  1. Direct-to-Consumer Drug Advertisements and the Informed Patient: A Legal, Ethical, and Content Analysis

    American Business Law Journal

    Volume 50, Issue 4, Winter 2013, Pages: 729–778, Joshua E. Perry, Anthony D. Cox and Dena Cox

    Version of Record online : 19 NOV 2013, DOI: 10.1111/ablj.12019

  2. You have free access to this content
    Drug promotion tactics-yet another pharma deception?

    International Journal of Clinical Practice

    Volume 68, Issue 6, June 2014, Pages: 662–665, A. Tagore

    Version of Record online : 18 MAY 2014, DOI: 10.1111/ijcp.12204

  3. The control of prescription drug advertising: A controversial issue

    Clinical Pharmacology & Therapeutics

    Volume 68, Issue 6, December 2000, Pages: 583–585, P. Jaillon

    Version of Record online : 12 DEC 2000, DOI: 10.1067/mcp.2000.111947

  4. You have free access to this content
    A stand against drug company advertising

    Emergency Medicine Australasia

    Volume 23, Issue 3, June 2011, Page: 381, Daniel M Fatovich

    Version of Record online : 14 JUN 2011, DOI: 10.1111/j.1742-6723.2011.01427.x

  5. Drug Advertising, Continuing Medical Education, and Physician Prescribing: A Historical Review and Reform Proposal

    The Journal of Law, Medicine & Ethics

    Volume 38, Issue 4, Winter 2010, Pages: 807–815, Marc A. Rodwin

    Version of Record online : 24 NOV 2010, DOI: 10.1111/j.1748-720X.2010.00534.x

  6. Law Enforcement as Legal Mobilization: Reforming the Pharmaceutical Industry Through Government Litigation

    Law & Social Inquiry

    Volume 40, Issue 1, Winter 2015, Pages: 123–151, Paul Nolette

    Version of Record online : 13 AUG 2014, DOI: 10.1111/lsi.12094

  7. You have free access to this content
    DRUG ADVERTISING IN MEDICAL JOURNALS

    British Journal of Clinical Pharmacology

    Volume 3, Issue 6, December 1976, Pages: 1057–1060, A.H. MORGAN, T.A. JEFFERS, J.C. PETRIE and W. WALKER

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1976.tb00358.x

  8. On the need for probity when physicians interact with industry

    Internal Medicine Journal

    Volume 36, Issue 4, April 2006, Pages: 265–269, I. A. Scott

    Version of Record online : 9 MAR 2006, DOI: 10.1111/j.1445-5994.2006.01047.x

  9. PHARMACEUTICAL PROMOTION IN NEW ZEALAND

    Community Health Studies

    Volume 12, Issue 3, September 1988, Pages: 264–272, Joel Lexchin

    Version of Record online : 12 FEB 2010, DOI: 10.1111/j.1753-6405.1988.tb00586.x

  10. A literature review and meta-analysis of drug company–funded mental health websites

    Acta Psychiatrica Scandinavica

    Volume 128, Issue 6, December 2013, Pages: 422–433, J. Read and A. Cain

    Version of Record online : 10 MAY 2013, DOI: 10.1111/acps.12146

  11. You have full text access to this Open Access content
    Direct-to-consumer advertising of pharmaceuticals: developed countries experiences and Turkey

    Health Expectations

    Volume 10, Issue 1, March 2007, Pages: 4–15, Semih Semin, Şahbal Aras and Dilek Guldal

    Version of Record online : 11 SEP 2006, DOI: 10.1111/j.1369-7625.2006.00411.x

  12. You have free access to this content
    From Lydia Pinkham to Queen Levitra: direct-to-consumer advertising and medicalisation

    Sociology of Health & Illness

    Volume 30, Issue 6, September 2008, Pages: 825–838, Peter Conrad and Valerie Leiter

    Version of Record online : 28 AUG 2008, DOI: 10.1111/j.1467-9566.2008.01092.x

  13. A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection

    The Milbank Quarterly

    Volume 84, Issue 4, December 2006, Pages: 659–699, JULIE DONOHUE

    Version of Record online : 10 NOV 2006, DOI: 10.1111/j.1468-0009.2006.00464.x

  14. You have free access to this content
    Health economists meet the fourth tempter: drug dependency and scientific discourse

    Health Economics

    Volume 9, Issue 8, December 2000, Pages: 659–667, Steve Morgan, Morris Barer and Robert Evans

    Version of Record online : 27 DEC 2000, DOI: 10.1002/1099-1050(200012)9:8<659::AID-HEC578>3.0.CO;2-0

  15. Ethical and practical implications of pharmaceutical direct-to-consumer advertising

    International Journal of Nonprofit and Voluntary Sector Marketing

    Volume 13, Issue 1, February 2008, Pages: 73–87, Janet Hoek

    Version of Record online : 11 SEP 2007, DOI: 10.1002/nvsm.319

  16. What Nurse Practitioners Should Know About Direct-to-Consumer Advertising of Prescription Medications

    Journal of the American Academy of Nurse Practitioners

    Volume 15, Issue 7, July 2003, Pages: 297–304, Pamela Hallquist Viale

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1745-7599.2003.tb01312.x

  17. You have free access to this content
    Direct-to-Consumer Prescription Drug Advertising and the Public

    Journal of General Internal Medicine

    Volume 14, Issue 11, November 1999, Pages: 651–657, Robert A. Bell, Richard L. Kravitz and Michael S. Wilkes

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1525-1497.1999.01049.x

  18. You have free access to this content
    Disease mongering and drug marketing

    EMBO reports

    Volume 6, Issue 7, July 2005, Pages: 612–614, Howard Wolinsky

    Version of Record online : 1 JUL 2005, DOI: 10.1038/sj.embor.7400476

  19. You have free access to this content
    Conflicts of interest in psychiatry: Strategies to cultivate literacy in daily practice

    Psychiatry and Clinical Neurosciences

    Volume 68, Issue 7, July 2014, Pages: 489–497, Rumiko Shimazawa and Masayuki Ikeda

    Version of Record online : 19 JUN 2014, DOI: 10.1111/pcn.12201

  20. Misleading drug promotion—no sign of improvements

    Pharmacoepidemiology and Drug Safety

    Volume 13, Issue 11, November 2004, Pages: 797–799, Peter R. Mansfield and David Henry

    Version of Record online : 8 MAR 2004, DOI: 10.1002/pds.953